Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device

READ MORE